Athira Pharma Inc ATHA

NAS: ATHA | ISIN: US04746L1044   16/05/2025
0,272 USD (-2,54%)
(-2,54%)   16/05/2025

10 juni 2024 · Glancy Prongay & Murray LLP and Labaton Keller Sucharow LLP Announce Proposed Class Action Settlement on Behalf of Purchasers of the Publicly Traded Common Stock of Athira Pharma, Inc. - (NASDAQ: ATHA) · Persbericht

14 mei 2022 · ATHIRA PHARMA INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Athira Pharma, Inc. - ATHA · Persbericht

24 augustus 2021 · ATHIRA PHARMA 24 HOUR DEADLINE ALERT: FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuits Against Athira Pharma, Inc. - ATHA · Persbericht

21 augustus 2021 · FINAL NOTICE: Investors with Substantial Losses Have Opportunity to Lead the Athira Pharma, Inc. Class Action Lawsuit - ATHA · Persbericht

19 augustus 2021 · DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Athira Pharma, Inc. Securities Fraud Class Action Lawsuit · Persbericht

11 augustus 2021 · Important Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Athira Pharma, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit · Persbericht

5 augustus 2021 · Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Athira Pharma, Inc. (ATHA) · Persbericht

26 juli 2021 · Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Athira Pharma, Inc. · Persbericht

21 juli 2021 · Class Action Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Athira Pharma, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit · Persbericht

13 juli 2021 · ATHIRA PHARMA INVESTOR NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Athira Pharma, Inc. Class Action Lawsuit - ATHA · Persbericht

12 juli 2021 · ATHA INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Athira Pharma, Inc. · Persbericht

9 juli 2021 · Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Athira Pharma, Inc. (ATHA) · Persbericht

30 juni 2021 · Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Athira Pharma, Inc. - ATHA · Persbericht

30 juni 2021 · ATHA INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Athira Pharma, Inc. · Persbericht

29 juni 2021 · HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Athira Pharma (ATHA) Investors to Contact Firm's Attorneys Now, Securities Fraud Case Filed · Persbericht

23 juni 2021 · HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Athira Pharma (ATHA) Investors to Contact Firm's Attorneys Now, Firm Investigating Possible Securities Law Violations · Persbericht

21 juni 2021 · Ademi LLP Investigates Claims of Securities Fraud against Athira Pharma, Inc. · Persbericht

18 juni 2021 · Washington State University to review claims of research misconduct · Persbericht

2 maart 2021 · Athira Pharma to Present at H.C. Wainwright & Co. Global Life Sciences Conference · Persbericht

7 januari 2021 · Athira Pharma to Present at the 39th Annual J.P. Morgan Healthcare Conference · Persbericht

Mijn selecties